LH
Labcorp Holdings Inc. · Healthcare
CEO, Covance Drug Development Paul R Kirchgraber sold $933K of Labcorp Holdings Inc.
Sold$932,707
$216.91Price
4,300Shares
−25%Stake
What LH did after the filing
- The stock from Tue, May 23 open, $187.29
- +11.2%
- S&P 500, same days
- +5.5%
Measured over 30 trading days, to the Jul 7 close.
Traded Fri, May 19. Filed Tue, May 23, 4:06 AM ET, before the open. Returns use the May 23 open and the Jul 7 close. Not investment advice.